International AIDS Vaccine Initiative, New York, New York.
Department of Epidemiology and Biostatistics, University of California-San Francisco.
J Infect Dis. 2019 Jul 2;220(3):432-441. doi: 10.1093/infdis/jiz127.
Few human immunodeficiency virus (HIV)-infected persons can maintain low viral levels without therapeutic intervention. We evaluate predictors of spontaneous control of the viral load (hereafter, "viral control") in a prospective cohort of African adults shortly after HIV infection. Viral control was defined as ≥2 consecutively measured viral loads (VLs) of ≤10 000 copies/mL after the estimated date of infection, followed by at least 4 subsequent measurements for which the VL in at least 75% was ≤10 000 copies/mL in the absence of ART. Multivariable logistic regression characterized predictors of viral control. Of 590 eligible volunteers, 107 (18.1%) experienced viral control, of whom 25 (4.2%) maintained a VL of 51-2000 copies/mL, and 5 (0.8%) sustained a VL of ≤50 copies/mL. The median ART-free follow-up time was 3.3 years (range, 0.3-9.7 years). Factors independently associated with control were HIV-1 subtype A (reference, subtype C; adjusted odds ratio [aOR], 2.1 [95% confidence interval {CI}, 1.3-3.5]), female sex (reference, male sex; aOR, 1.8 [95% CI, 1.1-2.8]), and having HLA class I variant allele B*57 (reference, not having this allele; aOR, 1.9 [95% CI, 1.0-3.6]) in a multivariable model that also controlled for age at the time of infection and baseline CD4+ T-cell count. We observed strong associations between infecting HIV-1 subtype, HLA type, and sex on viral control in this cohort. HIV-1 subtype is important to consider when testing and designing new therapeutic and prevention technologies, including vaccines.
在感染 HIV 后不久,我们对一个前瞻性的非洲成年人队列进行了研究,评估了自然控制病毒载量(以下简称“病毒控制”)的预测因素。病毒控制定义为在感染估计日期后至少连续两次测量到病毒载量(VL)≤10000 拷贝/ml,随后至少进行了 4 次测量,其中至少 75%的 VL 在未接受 ART 的情况下≤10000 拷贝/ml。多变量逻辑回归分析了病毒控制的预测因素。在 590 名合格的志愿者中,有 107 名(18.1%)经历了病毒控制,其中 25 名(4.2%)维持了 51-2000 拷贝/ml 的 VL,5 名(0.8%)维持了≤50 拷贝/ml 的 VL。无 ART 随访时间中位数为 3.3 年(范围 0.3-9.7 年)。与控制相关的独立因素包括 HIV-1 亚型 A(参考,亚型 C;调整后的优势比[aOR],2.1[95%置信区间{CI},1.3-3.5])、女性(参考,男性;aOR,1.8[95% CI,1.1-2.8])和 HLA Ⅰ类变异等位基因 B*57(参考,没有这个等位基因;aOR,1.9[95% CI,1.0-3.6])。在多变量模型中,该模型还控制了感染时的年龄和基线 CD4+T 细胞计数。在该队列中,我们观察到感染 HIV-1 亚型、HLA 类型和性别与病毒控制之间存在很强的关联。在测试和设计新的治疗和预防技术(包括疫苗)时,HIV-1 亚型很重要。